Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities

Cell Mol Life Sci. 2015 Apr;72(8):1537-57. doi: 10.1007/s00018-014-1814-x. Epub 2015 Jan 1.

Abstract

Research on the nanoscale membrane structures known as lipid rafts is relevant to the fields of cancer biology, inflammation and ischaemia. Lipid rafts recruit molecules critical to signalling and regulation of the invasion process in malignant cells, the leukocytes that provide immunity in inflammation and the endothelial cells that build blood and lymphatic vessels, as well as the patterning of neural networks. As angiogenesis is a common denominator, regulation of receptors and signalling molecules critical to angiogenesis is central to the design of new approaches aimed at reducing, promoting or normalizing the angiogenic process. The goal of this review is to highlight some of the key issues that indicate the involvement of endothelial cell lipid rafts at each step of so-called 'sprouting angiogenesis', from stimulation of the vascular endothelial growth factor to the choice of tip cells, activation of migratory and invasion pathways, recruitment of molecules that guide axons in vascular patterning and maturation of blood vessels. Finally, the review addresses opportunities for future studies to define how these lipid domains (and their constituents) may be manipulated to stimulate the so-called 'normalization' of vascular networks within tumors, and be identified as the main target, enabling the development of more efficient chemotherapeutics and cancer immunotherapies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Axons / metabolism
  • Blood Vessels / metabolism*
  • Caveolins / metabolism
  • Endothelial Cells / metabolism
  • Humans
  • Membrane Microdomains / metabolism*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neovascularization, Pathologic
  • Signal Transduction
  • Vascular Endothelial Growth Factors / metabolism

Substances

  • Caveolins
  • Vascular Endothelial Growth Factors